3D Bioprinting Engineers create cutting-edge technologies that layer living cells and biomaterials to build three-dimensional biological structures. They focus on creating bioinks that maintain cell viability and support the mechanical properties needed for the printed constructs to hold shape and function. By integrating principles of mechanical engineering, materials science, and cell biology, they build printers and software that can fabricate intricate, tissue-like architectures. Their work enables the production of personalized biological models for applications in research, drug testing, and therapeutic development.
Beyond printer and bioink formulation, 3D Bioprinting Engineers collaborate with interdisciplinary teams to address challenges like nutrient delivery, vascularization, and structural integrity of the constructs. They optimize printing protocols to improve cell survival and ensure the mechanical stability of the printed tissues. Their contributions accelerate the development of customized medical treatments and innovative therapeutic options. Their expertise is vital for advancing biofabrication technologies. By combining engineering innovation with biological systems, they unlock new possibilities in healthcare. They are driving progress toward the development of cutting-edge regenerative therapies and experimental tools. They continuously explore new materials and methods to enhance print resolution and tissue complexity. Their work supports the creation of more reliable and scalable biofabrication platforms. Through ongoing innovation, they drive progress toward practical clinical applications.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy